Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Recursion Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $435.0K in total
Insiders trading
2
Net value
−$435.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Recursion Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Recursion Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Taylor Ben RChief Financial Officer1,071,462Sep 16, 202612
Khan NajatCEO and President2,072,890Sep 10, 202610
Borgeson BlakeDirector6,158,287Sep 2, 202611
Hallett DavidChief Scientific Officer1,043,837Aug 18, 20264
Dar ZavainDirector240,764Jul 2, 20265
Li Dean YDirector1,473,329Jul 2, 20265
Hershberg RobertDirector162,156Jun 22, 20261
Sun Elaine DDirector135,981Jun 22, 20261
Michor FranziskaDirector215,477Jun 22, 20261
Bumpus NamandjeDirector127,632Jun 22, 20262
Gibson ChristopherDirector883,735Jun 5, 202618
Mauro David JChief Medical Officer225,429Nov 19, 20240
Secora MichaelChief Financial Officer1,487,694Nov 19, 20240
Larson Tina MarriottPresident and COO506,852Nov 19, 20240
Burrell Terry-AnnDirector71,254Jul 3, 20240
Chavez R. MartinDirector60,078Apr 3, 20240
Virani ShafiqueChief Business Officer136,748Jan 18, 20240
Bogue ZacharyDirector, 10% Owner9,378Jul 6, 20230
Mamoura Diversified Global Holding PJSC10% Owner12,985,927IndirectMar 3, 20230
Mubadala Investment Co PJSC10% Owner12,985,927IndirectMar 3, 20230
Doyle RamonaChief Medical Officer121,110May 18, 20220
Lux Ventures IV, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Lux Venture Partners IV, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Hebert PeterOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Partners, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Opportunities, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Wolfe JoshOther: Former 10% Owner13,021,519Dec 9, 20210
Mic Capital Partners (Public) (US) Im, LLCOther: See remarks–Nov 3, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 22, 2021 (view filing)Nov 184 daysBorgeson BlakeDirectorSSaleClass A Common Stock−9.63K$18.91−$182.0K−0.1%7.68M after2 lots
Nov 22, 2021 (view filing)Nov 184 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−2.50K$18.92−$47.3K−4.8%50.0K after2 lots
Dec 9, 2021 (view filing)Nov 17-1922 daysLi Dean YDirectorSSaleClass A Common Stock−19.1K$20.15−$384.9K−1.4%1.33M afterAmended2 lots
Dec 9, 2021 (view filing)Dec 72 daysLi Dean YDirectorSSaleClass A Common Stock−15.9K$20.48−$325.6K−1.2%1.31M after2 lots
Dec 9, 2021 (view filing)Dec 72 daysBorgeson BlakeDirectorSSaleClass A Common Stock−9.63K$20.31−$195.5K−0.1%7.67M after3 lots
Dec 9, 2021 (view filing)Dec 72 daysGibson ChristopherChief Executive OfficerSSaleClass B Common Stock−16.7K$20.48−$341.3K−0.2%8.20M after2 lots
Dec 9, 2021 (view filing)Dec 72 daysGibson ChristopherChief Executive OfficerSSaleClass B Common Stock−3.13K$20.51−$64.1K−2.1%146.9K after2 lots
Dec 10, 2021 (view filing)Dec 8-92 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−11.8K$20.14−$236.6K−33.4%23.5K after3 lots
Dec 15, 2021 (view filing)Dec 132 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−100$20.02−$2.00K−0.4%23.5K after
Dec 20, 2021 (view filing)Dec 164 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−200$20.01−$4.00K−0.8%23.5K after
Dec 20, 2021 (view filing)Dec 164 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−2.50K$18.74−$46.9K−5.0%47.5K after3 lots
Dec 23, 2021 (view filing)Dec 212 daysBorgeson BlakeDirectorSSaleClass A Common Stock−9.63K$18.75−$180.5K−0.1%7.66M after
Jan 5, 2022 (view filing)Jan 41 dayBorgeson BlakeDirectorSSaleClass A Common Stock−9.63K$18.03−$173.5K−0.1%7.65M after
Jan 14, 2022 (view filing)Jan 13-141 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−341.0K$13.76−$4.69M−93.6%23.5K after3 lots
Feb 2, 2022 (view filing)Jan 312 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−19.9K$11.73−$232.9K−45.8%23.5K after
Feb 24, 2022 (view filing)Feb 222 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−100.0K$10.22−$1.02M−29.9%234.0K after
Mar 9, 2022 (view filing)Mar 72 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−300.0K$7.30−$2.19M−56.2%234.0K after
Mar 15, 2022 (view filing)Mar 11-154 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−336.1K$6.48−$2.18M−59.0%234.0K after3 lots
Apr 7, 2022 (view filing)Apr 52 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−34.5K$7.44−$256.3K−11.6%262.1K after2 lots
Apr 7, 2022 (view filing)Apr 52 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$7.31−$18.3K−100.0%0 after3 lots
Apr 8, 2022 (view filing)Apr 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−35.8K$6.77−$242.6K−11.0%288.7K after2 lots
Apr 8, 2022 (view filing)Apr 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$6.56−$16.4K−100.0%0 after3 lots
Apr 11, 2022 (view filing)Apr 74 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.7K$6.54−$240.3K−10.5%314.5K after2 lots
Apr 11, 2022 (view filing)Apr 74 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$6.51−$16.3K−100.0%0 after3 lots
Apr 12, 2022 (view filing)Apr 84 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.9K$6.59−$243.1K−9.8%340.1K after2 lots
Apr 12, 2022 (view filing)Apr 84 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$6.71−$16.8K−100.0%0 after3 lots
Apr 18, 2022 (view filing)Apr 144 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−34.5K$7.56−$261.0K−8.6%368.1K after2 lots
Apr 18, 2022 (view filing)Apr 144 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$7.51−$18.8K−100.0%0 after3 lots
Apr 20, 2022 (view filing)Apr 182 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−35.8K$6.84−$245.1K−8.3%394.8K after2 lots
Apr 20, 2022 (view filing)Apr 182 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$6.71−$16.8K−100.0%0 after3 lots
Apr 25, 2022 (view filing)Apr 21-224 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−75.1K$6.17−$463.7K−14.4%444.7K after4 lots
Apr 25, 2022 (view filing)Apr 21-224 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−5.00K$6.09−$30.5K−100.0%0 after6 lots
May 2, 2022 (view filing)Apr 28-294 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−75.7K$6.14−$464.4K−13.3%494.1K after4 lots
May 2, 2022 (view filing)Apr 28-294 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−5.00K$6.19−$30.9K−100.0%0 after6 lots
May 6, 2022 (view filing)May 4-52 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−50.3K$6.47−$325.7K−9.0%512.0K after3 lots
May 6, 2022 (view filing)May 4-52 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−5.00K$6.46−$32.3K−100.0%0 after6 lots
Jun 6, 2022 (view filing)Jun 24 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−39.7K$6.09−$241.7K−7.1%516.3K after2 lots
Jun 6, 2022 (view filing)Jun 24 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$6.34−$15.9K−100.0%0 after3 lots
Jul 8, 2022 (view filing)Jul 71 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−37.1K$9.05−$336.1K−6.6%528.9K after2 lots
Jul 8, 2022 (view filing)Jul 71 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$9.07−$22.7K−100.0%0 after3 lots
Aug 5, 2022 (view filing)Aug 41 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.8K$9.49−$349.5K−6.4%541.8K after2 lots
Aug 5, 2022 (view filing)Aug 41 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$9.45−$23.6K−100.0%0 after3 lots
Aug 17, 2022 (view filing)Aug 161 dayLarson Tina MarriottPresident and COOSSaleClass A Common Stock−16.0K$12.60−$201.6K−5.1%295.1K after
Aug 17, 2022 (view filing)Aug 161 dayVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−30.0K$12.61−$378.3K−23.3%98.8K after
Sep 2, 2022 (view filing)Sep 11 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.6K$10.34−$378.0K−6.2%549.3K after2 lots
Sep 2, 2022 (view filing)Sep 11 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$10.50−$26.3K−100.0%0 after3 lots
Sep 16, 2022 (view filing)Sep 151 dayVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−10.0K$13.37−$133.7K−9.6%93.8K after2 lots
Oct 3, 2022 (view filing)Sep 294 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−16.0K$10.86−$173.8K−7.2%205.1K after2 lots
Oct 7, 2022 (view filing)Oct 61 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.1K$11.58−$417.4K−6.0%563.0K after2 lots
Oct 7, 2022 (view filing)Oct 61 dayGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−2.50K$11.64−$29.1K−100.0%0 after3 lots